@article{31071, keywords = {Therapeutics, leprosy, Drug Combinations, Combined Modality Therapy}, author = {Cruz RCS and Bührer-Sékula S and Penna ML and Penna GO and Talhari S}, title = {Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients.}, abstract = {
In this review, the most relevant and current epidemiological data, the main clinical, laboratory and therapeutical aspects of leprosy are presented. Detailed discussion of the main drugs used for leprosy treatment, their most relevant adverse effects, evolution of the therapeutic regimen, from dapsone as a monotherapy to the proposed polychemotherapy by World Health Organization (WHO) can be found in this CME. We specifically highlight the drug acceptability, reduction in treatment duration and the most recent proposal of a single therapeutic regimen, with a fixed six months duration, for all clinical presentations, regardless of their classification.
}, year = {2017}, journal = {Anais brasileiros de dermatologia}, volume = {92}, pages = {761-773}, issn = {1806-4841}, url = {http://www.scielo.br/pdf/abd/v92n6/0365-0596-abd-92-06-0761.pdf}, doi = {10.1590/abd1806-4841.20176724}, language = {eng}, }